cbdMD, Inc. (YCBD)
0.488
-0.02
(-4.11%)
USD |
NYAM |
Aug 24, 16:00
cbdMD EPS Diluted (Quarterly) : -0.1129 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.1129 |
| March 31, 2026 | -0.084 |
| December 31, 2025 | -0.036 |
| September 30, 2025 | -0.0762 |
| June 30, 2025 | -0.2125 |
| March 31, 2025 | -1.903 |
| December 31, 2024 | -1.732 |
| September 30, 2024 | -2.346 |
| June 30, 2024 | -0.1505 |
| March 31, 2024 | -1.355 |
| December 31, 2023 | -0.6744 |
| September 30, 2023 | -5.700 |
| June 30, 2023 | -1.164 |
| March 31, 2023 | -1.737 |
| December 31, 2022 | -3.695 |
| September 30, 2022 | -11.59 |
| June 30, 2022 | -24.76 |
| March 31, 2022 | -4.318 |
| Date | Value |
|---|---|
| December 31, 2021 | -15.69 |
| September 30, 2021 | -3.396 |
| June 30, 2021 | 0.7155 |
| March 31, 2021 | -11.00 |
| December 31, 2020 | -8.197 |
| September 30, 2020 | -5.489 |
| June 30, 2020 | -7.935 |
| March 31, 2020 | 17.82 |
| December 31, 2019 | 20.27 |
| September 30, 2019 | 20.80 |
| June 30, 2019 | -429.93 |
| March 31, 2019 | -1126.38 |
| December 31, 2018 | -75.56 |
| September 30, 2018 | -4.928 |
| June 30, 2018 | 1.35 |
| March 31, 2018 | 7.65 |
| December 31, 2017 | -7.20 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Tilray Brands, Inc. | -0.4291 |
| Organogenesis Holdings, Inc. | -0.772 |
| Guardian Pharmacy Services, Inc. | 0.3426 |
| Nektar Therapeutics | -1.229 |
| Elite Pharmaceuticals, Inc. | 0.0052 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.127M |
| Revenue (Quarterly) | 5.554M |
| Total Expenses (Quarterly) | 6.681M |
| Enterprise Value | 5.522M |
| Gross Profit Margin (Quarterly) | 50.03% |
| Profit Margin (Quarterly) | -20.30% |
| Earnings Yield | -63.34% |
| Normalized Earnings Yield | -63.34 |